Incidence and Impact of Parvovirus B19 Infection in Seronegative Solid Organ Transplant Recipients

被引：8

作者：

Rezahosseini, Omid ^{[1
]}

Ekenberg, Christina ^{[2
]}

Moller, Dina Leth ^{[1
]}

Sorensen, Soren Schwartz ^{[3
,4
]}

Wareham, Neval Ete ^{[2
]}

Perch, Michael ^{[4
,5
]}

Gustafsson, Finn ^{[4
,6
]}

Rasmussen, Allan ^{[7
]}

Kirkby, Nikolai ^{[8
]}

Reekie, Joanne ^{[2
]}

Lundgren, Jens ^{[2
,4
]}

Nielsen, Susanne Dam ^{[1
,4
]}

机构：

[1] Univ Copenhagen, Rigshosp, Dept Infect Dis 8632, Viro Immunol Res Unit, Copenhagen, Denmark

[2] Univ Copenhagen, Rigshosp, Ctr Excellence Ku Hlth Immun & Infect, Dept Infect Dis, Copenhagen, Denmark

[3] Univ Copenhagen, Rigshosp, Dept Nephrol, Copenhagen, Denmark

[4] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark

[5] Univ Copenhagen, Rigshosp, Dept Cardiol, Sect Lung Transplantat, Copenhagen, Denmark

[6] Univ Copenhagen, Rigshosp, Dept Cardiol, Copenhagen, Denmark

[7] Univ Copenhagen, Rigshosp, Dept Surg Gastroenterol & Transplantat, Copenhagen, Denmark

[8] Univ Copenhagen, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark

来源：

JOURNAL OF INFECTIOUS DISEASES | 2021年 / 224卷 / 05期

基金：

新加坡国家研究基金会;

关键词：

organ transplant; parvovirus B19; human; polymerase chain reaction; incidence;

D O I：

10.1093/infdis/jiab024

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Routine monitoring of parvovirus B19 (B19V) the first 6 months posttransplantation was performed in 241 seronegative solid organ transplant (SOT) recipients. Incidence rates during the first month and the second to sixth months posttransplantation were 1.2 (95% confidence interval [CI], .33-3.2) and 0.21 (95% CI, .06-.57) per 100 recipients per month, respectively. Of the 6 SOT recipients with positive B19V polymerase chain reaction, 3 (50%) were admitted to hospital and 2 (33%) were treated with intravenous immunoglobulin. Thus, routine monitoring of B19V in seronegative SOT recipients may not be necessary. Targeted screening 1 month posttransplantation and screening upon clinical suspicion could be an alternative strategy.

引用

页码：865 / 869

页数：5

共 50 条

[31] Parvovirus B19 Infection
Mende, Marika
Sockel, Katja
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24): : 2361 - 2361
[32] Parvovirus B19 infection in an isolated pancreas transplant recipient
Onitilo, AA
Shaw, GR
TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4433 - 4435
[33] Relation between parvovirus B19 (PVV19) and cytomegalovirus (CMV) infection in renal transplant recipients
Melon, Santiago
Sampere, Angeles
Monteavaro, Camino G.
Banos, Mariano
Gomez, Ernesto
de Ona, Maria
TRANSPLANT INTERNATIONAL, 2007, 20 : 247 - 247
[34] PARVOVIRUS B19 INFECTION (PB19) IS AN IMPORTANT CAUSE OF HEPATIC INJURY IN LIVER TRANSPLANT RECIPIENTS
Shetty, Rajesh S.
Naides, Stanley J.
Collins, Thomas
Miller, Rachel
Voigt, Michael D.
HEPATOLOGY, 2011, 54 : 619A - 619A
[35] B19 virus infection in renal transplant recipients
Cavallo, R
Merlino, C
Re, D
Bollero, C
Bergallo, M
Lembo, D
Musso, T
Leonardi, G
Segoloni, GP
Ponzi, AN
JOURNAL OF CLINICAL VIROLOGY, 2003, 26 (03) : 361 - 368
[36] Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation
Ahsan, N
Holman, MJ
Gocke, CD
Groff, JA
Yang, HC
CLINICAL TRANSPLANTATION, 1997, 11 (04) : 265 - 270
[37] Effects of Parvovirus B19 Infection in Renal Transplant Recipients: A Retrospective Review of 3 Cases.
Krishnan, P.
Ramadas, P.
Rajendran, P.
Bhaskaran, M.
Molmenti, E.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 478 - 479
[38] Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients
Zhang, M.
Zhong, X.
Zhang, W.
Xu, J.
Zhang, M.
Shen, Y.
Wang, W.
Zheng, S.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 : 29 - 34
[39] Human Parvovirus B19 Infection Induced Pure Red Cell Aplasia in Liver Transplant Recipients
Zhang, Mangli
Zhong, Xun
Zhang, Wei
Xu, Jun
Zhang, Min
Shen, Yan
Wang, Weilin
Zheng, Shusen
TRANSPLANTATION, 2015, 99 : 176 - 177
[40] Parvovirus B19 infection-related complications in renal transplant recipients - Treatment with intravenous immunoglobulin
Moudgil, A
Shidban, H
Nast, CC
Bagga, A
Aswad, S
Graham, SL
Mendez, R
Jordan, SC
TRANSPLANTATION, 1997, 64 (12) : 1847 - 1850

← 1 2 3 4 5 →